Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
24.82
+0.82 (3.42%)
At close: Mar 9, 2026, 4:00 PM EDT
24.70
-0.12 (-0.48%)
After-hours: Mar 9, 2026, 6:20 PM EDT
Arcutis Biotherapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 42.91 | 71.34 | 88.4 | 53.64 | 96.45 | Upgrade
|
| Short-Term Investments | 178.08 | 156.62 | 183.46 | 355.95 | 290.61 | Upgrade
|
| Cash & Short-Term Investments | 220.98 | 227.96 | 271.86 | 409.59 | 387.06 | Upgrade
|
| Cash Growth | -3.06% | -16.15% | -33.63% | 5.82% | 36.08% | Upgrade
|
| Accounts Receivable | 146.23 | 73.07 | 25.81 | 8.46 | - | Upgrade
|
| Receivables | 146.23 | 73.07 | 25.81 | 8.46 | - | Upgrade
|
| Inventory | 22.63 | 14.53 | 13.13 | 7.51 | - | Upgrade
|
| Prepaid Expenses | 11.59 | 12.29 | 10.1 | 7.39 | 14.17 | Upgrade
|
| Restricted Cash | 0.31 | 0.62 | 0.93 | 1.23 | 1.54 | Upgrade
|
| Other Current Assets | 9.49 | 7.37 | 8.61 | 3.23 | - | Upgrade
|
| Total Current Assets | 411.23 | 335.82 | 330.43 | 437.41 | 402.77 | Upgrade
|
| Property, Plant & Equipment | 5.51 | 2.99 | 3.9 | 4.6 | 5.3 | Upgrade
|
| Other Intangible Assets | 14.81 | 9.48 | 6.44 | 7.19 | - | Upgrade
|
| Other Long-Term Assets | 1.42 | 0.6 | 0.6 | 0.08 | 0.08 | Upgrade
|
| Total Assets | 432.97 | 348.89 | 341.37 | 449.27 | 408.15 | Upgrade
|
| Accounts Payable | 12.53 | 14.22 | 11.99 | 8.83 | 7.35 | Upgrade
|
| Accrued Expenses | 116.31 | 66.79 | 33.94 | 28.32 | 25.54 | Upgrade
|
| Current Portion of Long-Term Debt | 1 | - | - | - | - | Upgrade
|
| Current Portion of Leases | - | - | 0.74 | 0.66 | 0.43 | Upgrade
|
| Total Current Liabilities | 129.84 | 81.01 | 46.67 | 37.81 | 33.33 | Upgrade
|
| Long-Term Debt | 107.96 | 107.2 | 201.8 | 197.77 | 72.35 | Upgrade
|
| Long-Term Leases | 5.27 | 2.56 | 3.38 | 4.12 | 4.77 | Upgrade
|
| Other Long-Term Liabilities | 0.43 | 0.57 | 0.85 | - | 0.03 | Upgrade
|
| Total Liabilities | 243.49 | 191.35 | 252.7 | 239.69 | 110.48 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 1,328 | 1,279 | 1,071 | 930.43 | 706.23 | Upgrade
|
| Retained Earnings | -1,138 | -1,122 | -981.9 | -719.76 | -408.31 | Upgrade
|
| Comprehensive Income & Other | -0.04 | -0.01 | 0 | -1.09 | -0.26 | Upgrade
|
| Total Common Equity | 189.48 | 157.54 | 88.67 | 209.58 | 297.68 | Upgrade
|
| Shareholders' Equity | 189.48 | 157.54 | 88.67 | 209.58 | 297.68 | Upgrade
|
| Total Liabilities & Equity | 432.97 | 348.89 | 341.37 | 449.27 | 408.15 | Upgrade
|
| Total Debt | 114.23 | 109.77 | 205.92 | 202.54 | 77.56 | Upgrade
|
| Net Cash (Debt) | 106.76 | 118.19 | 65.95 | 207.05 | 309.5 | Upgrade
|
| Net Cash Growth | -9.67% | 79.22% | -68.15% | -33.10% | 10.74% | Upgrade
|
| Net Cash Per Share | 0.84 | 0.98 | 0.95 | 3.76 | 6.26 | Upgrade
|
| Filing Date Shares Outstanding | 124.03 | 118.64 | 96.81 | 61.08 | 50.38 | Upgrade
|
| Total Common Shares Outstanding | 123.33 | 117.85 | 96.79 | 61.04 | 50.26 | Upgrade
|
| Working Capital | 281.39 | 254.81 | 283.76 | 399.6 | 369.45 | Upgrade
|
| Book Value Per Share | 1.54 | 1.34 | 0.92 | 3.43 | 5.92 | Upgrade
|
| Tangible Book Value | 174.67 | 148.06 | 82.23 | 202.39 | 297.68 | Upgrade
|
| Tangible Book Value Per Share | 1.42 | 1.26 | 0.85 | 3.32 | 5.92 | Upgrade
|
| Machinery | 2.62 | 1.93 | 1.79 | 1.36 | 1.12 | Upgrade
|
| Leasehold Improvements | 1.57 | 1.57 | 1.57 | 1.57 | 1.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.